This week, preliminary results from two phase 1 trials were published in the New England Journal of Medicine. Overall, the trials demonstrated safety and the Read More
Washington Post: Why aren’t we producing medications for looming global disease threats? Mel Spigelman, physician and president and chief executive of TB Alliance “…[A new Global Health Technologies Coalition] analysis reveals that over the past six years, [U.S.] taxpayer funding for global health research has been stagnant or declining. … Managing health threats through emergency…More
Susan Reef, MD, Rubella Team Lead, Global Immunization Division When I started focusing on rubella in 1994, it was mainly recognized as a significant public health problem in high-income countries. When the public health community realized that rubella and congenital rubella syndrome (CRS) were actually significant public health issues in the entire region of the Americas, things took a turn and an elimination goal was set for 2010. In the pre-vaccine era, some 20,000 infants were born each year in the Americas region with CRS and one or more of its devastating birth defects. I look at our success in achieving the elimination goal —which occurred in 2009, a year before the target date—in terms of the lives it impacted: 20,000 of them, born free of CRS disabilities each year since then.
Wall Street Journal: NIH Expands Testing of Ebola Drugs and Vaccines Into New Countries “…The NIH randomized controlled study of ZMapp has expanded from Liberia into Sierra Leone, where about 40 patients have been enrolled so far, according to H. Clifford Lane, deputy director of the NIH’s National Institute of Allergy and Infectious Diseases. He…More
Agence France-Presse: Thousands of Liberians in ‘post-Ebola syndrome’ study “Liberia launched a five-year study on Wednesday to unravel the mystery of the long-term health effects that plague Ebola survivors and assess how long they should go without sex…” (Dosso, 6/17). Reuters: Ebola vaccines in limbo expose need for more speed in trials “Drugmakers’ plans to…More
New York Times: Letter to the Editor: Fighting the Tuberculosis Threat Thomas G. Evans, CEO of Advancing Tuberculosis Vaccines for the World “…[T]hroughout the world, nine million people are diagnosed with active TB every year and 1.5 million die — as many people die from HIV. … Decades of neglect have meant that a concerted…More
The Hill: Obama administration pushes for faster Ebola test “The Department of Health and Human Services (HHS) on Friday announced a contract to develop a faster test for Ebola, as well as grants for nine regional treatment centers…” (Sullivan, 6/12). PBS NewsHour: Why testing an Ebola vaccine isn’t so easy “In Sierra Leone and Liberia,…More
Vatican Radio: Holy See: Poor countries need better access to medicines “The Vatican has called for waivers for the least-developed countries from certain obligations of intellectual property treaties in order to give them better access to essential medicines and vaccines. Archbishop Silvano M. Tomasi, permanent representative of the Holy See to the United Nations and…More
Agence France-Presse: Nigeria makes final push to stamp out polio “Health workers move from door to door in the rural Sumaila district of Kano state, northern Nigeria, administering oral polio vaccines to children under five. It could be any other vaccination drive but the program has extra importance in Nigeria, where there has not been…More
The Guardian: Brazil considers vaccines and GM mosquitoes to tackle dengue fever “…Since January, Brazil’s health ministry has spent R$150m (US$50m) fighting dengue. Most of the money has gone to health authorities in towns like Estrela d’Oeste, to fund preventative measures, such as house visits and education programs. … But given the difficulty of halting…More
As low income countries experience economic transition, characterized by rapid economic growth and increased government spending potential in health, they have increased fiscal space to support and sustain more of their own health programmes, decreasing need for donor development assistance.
Reuters: Meningitis cases triple in two weeks in Niger, more than 400 dead — WHO “An outbreak of meningitis with ‘unprecedented features’ is spreading rapidly in Niger, with a tripling of cases in the past two weeks, hundreds of deaths so far this year, and vaccines in short supply, the World Health Organization said on…More
Devex: Global partnerships key to eradicating TB Lewis Schrager, vice president of scientific affairs at Aeras “…The fourth Global Forum on TB Vaccines [held in Shanghai in late April] presented both a sense of significant accomplishment in what the TB vaccine development field has learned thus far, and a sobering sense of the daunting challenges…More
Agence France-Presse: Meningitis epidemic in Niger kills more than 250 “A meningitis epidemic in poverty-stricken Niger has claimed 252 lives since January, a health official said Monday, warning the country was short of vaccines to fight the outbreak. ‘As of May 3,252 people died out of a total of 3,304 cases,’ said Niger’s epidemics surveillance…More
USAID: Saving Children’s Lives: USAID’s Support for Immunization This fact sheet describes USAID’s immunization activities, as the agency “works closely with partners around the world, including national governments, UNICEF, the World Health Organization, the GAVI Vaccine Alliance, and others, to extend access to life-saving vaccines…” (April 2015).
Agence France-Presse: Rubella is gone from the Americas: global health authorities “Improved vaccine campaigns have led to the elimination of rubella — an infectious disease that can cause birth defects — from North, Central, and South America, global health authorities said Wednesday…” (4/29). Associated Press: German measles officially eliminated in North, South America “…Vaccines against…More
LiveMint: Gavi to withdraw funding to India “In a move that could potentially undermine India’s immunization program, the Global Alliance for Vaccines and Immunization (Gavi) plans to withdraw funding to the country. … Gavi is now in talks with the government to decide the course of action for the next five years, [Seth Berkley, chief…More